Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy and cardiovascular disease

G Samsioe1

  • 1Department of Obstetrics & Gynecology, Lund University Hospital, Sweden.

International Journal of Fertility and Menopausal Studies
|January 1, 1993
PubMed
Summary

Hormone replacement therapy (HRT) significantly reduces cardiovascular disease mortality in postmenopausal women, despite physician concerns. Research indicates HRT offers substantial cardiovascular benefits beyond lipid improvements.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased blood cadmium levels were not associated with increased fracture risk but with increased total mortality in women: the Malmö Diet and Cancer Study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Optimal tolerability of ultra-low-dose continuous combined 17beta-estradiol and norethisterone acetate: laboratory and safety results.

Climacteric : the journal of the International Menopause Society·2009
Same author

Sociodemographic risk factors of metabolic syndrome in middle-aged women: results from a population-based study of Swedish women, The Women's Health in the Lund Area (WHILA) Study.

Climacteric : the journal of the International Menopause Society·2008
Same author

Symptoms in peri- and postmenopausal women in relation to testosterone concentrations: data from The Women's Health in the Lund Area (WHILA) study.

Climacteric : the journal of the International Menopause Society·2008
Same author

Could androgens protect middle-aged women from cardiovascular events? A population-based study of Swedish women: The Women's Health in the Lund Area (WHILA) Study.

Climacteric : the journal of the International Menopause Society·2007
Same author

Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2007

Area of Science:

  • Cardiovascular health
  • Menopause research
  • Hormone therapy

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in industrialized nations, particularly among postmenopausal women.
  • Research on CVD in postmenopausal women is less extensive than for osteoporosis or cancer, despite a dramatic increase in risk post-menopause.
  • Physician concerns regarding hormone replacement therapy (HRT) side effects like hypertension and thrombosis persist, potentially due to outdated information.

Purpose of the Study:

  • To evaluate the impact of hormone replacement therapy (HRT) on cardiovascular disease (CVD) incidence and mortality in postmenopausal women.
  • To address physician misconceptions about the risks of HRT in the context of CVD prevention.
  • To synthesize existing evidence on HRT's effects on cardiovascular risk factors.

Main Methods:

  • Systematic review and meta-analysis of epidemiological studies, including case-control and prospective cohort studies.
  • Analysis of approximately 20 studies conducted over the past 15 years.
  • Examination of HRT's effects on various cardiovascular risk factors, including lipids, peripheral vascular resistance, and prostanoids.

Main Results:

  • Multiple studies demonstrate a significant reduction in cardiovascular mortality for postmenopausal women using HRT, with some studies showing reductions greater than 50%.
  • While HRT benefits lipid profiles (HDL, LDL), these changes account for only 20-25% of the overall cardiovascular benefits.
  • HRT positively impacts other factors like peripheral vascular resistance and certain prostanoids, contributing to its cardioprotective effects.

Conclusions:

  • HRT is associated with a substantial decrease in cardiovascular mortality among postmenopausal women.
  • The cardioprotective benefits of HRT extend beyond lipid modification, involving other crucial physiological pathways.
  • Further research and physician education are warranted to address misconceptions and optimize HRT use for cardiovascular health in postmenopausal women.

Related Experiment Videos